Bioavailability of orally administered vitamins, minerals, and trace e
lements is subject to a complex set of influences. Still, administrati
ve regulation is necessary on how to quantify it. The most common appr
oach to this problem is to determine the fraction of an oral dose that
reaches the systemic circulation. For micronutrients, however, this a
pproach has to consider the physiological plasma concentration as well
as the mechanisms that regulate intestinal absorption and distributio
n of micronutrients between functional and storage compartments in res
ponse to the demand. The rate of exchange between these compartments h
as an impact on the delivery of such compounds into the plasma compart
ment as well as on the plasma clearance. Monitoring the area under the
plasma concentration time curve after oral administration is an inade
quate tool for bioavailability determination if there are substantial
impacts of homeostatic mechanisms on the plasma concentration of a mic
ronutrient. In nutritional science the term ''bioavailability'' encomp
asses the sum of impacts that may reduce or foster the metabolic utili
sation of a nutrient. Bioavailability in this sense can be quantified
by the rate by which deficiency symptoms are cured or by the weight ga
in during growth. Both of these endpoints, again, are influenced by ho
meostatic mechanisms. To exemplify the scope of impacts on parameters
that are commonly used to quantify the bioavailability of oral micronu
trient preparations the basic traits of homeostatic regulation are sum
marised and compared for iron, magnesium, vitamin A, folic acid, and v
itamin B-12. The mechanisms that adapt absorption, distribution, and e
xcretion of these five micronutrients to the demand differ to such an
extent that no common approach can be derived to consider these impact
s in bioavailability determination. In consequence, therefore, we reco
mmend to define and regulate individual strategies for bioavailability
testing for each micronutrient with regulated kinetics.